Boston Scientific earnings were $2.8B for the trailing 12 months ending Sep 30, 2025, with 54.9% growth year over year. The latest BSX earnings report on Sep 30, 2025 announced Q3 2025 earnings of $755.0M, down 5.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BSX reported annual earnings of $1.9B, with 18% growth.
BSX past earnings growth
How has BSX's earnings growth performed historically?
What were Boston Scientific's earnings last quarter?
On BSX's earnings call on Invalid Date, Boston Scientific (NYSE: BSX) reported Q3 2025 earnings per share (EPS) of $0.51, up 59.38% year over year. Total BSX earnings for the quarter were $755.00 million. In the same quarter last year, Boston Scientific's earnings per share (EPS) was $0.32.
As of the last Boston Scientific earnings report, Boston Scientific is currently profitable. Boston Scientific's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $2.79 billion, a 55.89% increase year over year.
What was BSX's earnings growth in the past year?
As of Boston Scientific's earnings date in Invalid Date, Boston Scientific's earnings has grown 54.92% year over year. This is 17.71 percentage points lower than the US Medical Devices industry earnings growth rate of 72.62%. BSX earnings in the past year totalled $2.79 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.